Insider purchase
Maraganore John bought $248.9K of Rapport Therapeutics
Maraganore John filed as Director of Rapport Therapeutics. The Form 4 was filed on Oct 22, 2026: 9,411 shares at an average of $26.45.
| Filed | Shares | Avg. price | Value | Holding change | Source |
|---|---|---|---|---|---|
| Oct 22, 2026 | 9,411 | $26.45 | $248.9K | New position | Form 4 on SEC |
| Total | 9,411 | $248.9K |
- Oct 22, 2026$248.9K
9,411 shares at $26.45, new position
Form 4 on SEC
Total9,411$248.9K
Values are rounded, so the rows may not add up exactly to the total.